Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hanna Saadani
Institutions:
The Netherlands Cancer Institute,
Amsterdam University Medical Centers,
Cancer Center Amsterdam,
Vrije Universiteit Amsterdam
Observed institutions:
The Netherlands Cancer Institute,
Amsterdam University Medical Centers,
Cancer Center Amsterdam,
Vrije Universiteit Amsterdam
ORCID:
0000-0001-8771-6834
Observed ORCID:
0000-0001-8771-6834
OpenAlex ID:
A5058653544
Metabolic Biomarker–Based BRAFV600 Mutation Association and Prediction in Melanoma
2019
·
Hanna Saadani
, Bernies van der Hiel
, et al.
·
Journal of Nuclear Medicine
·
28
PDF
Comparing [18F]FDG PET/CT response criteria in melanoma and lung cancer patients treated with immunotherapy: a systematic review
2022
·
Hanna Saadani
, Else A. Aalbersberg
, et al.
·
Clinical and Translational Imaging
·
7
Novel Clinical PET Tracers in the Pipeline for Melanoma
2025
·
Nora Jaber
, Hanna Saadani
, et al.
·
Current Oncology Reports
·
3
Pretreatment PET dissemination features as biomarkers for survival outcomes in melanoma patients treated with immune-checkpoint inhibitors
2025
·
Hanna Saadani
, Else A. Aalbersberg
, et al.
·
Scientific Reports
·
2
PDF
18 F-FDG PET/CT based BRAFV600 prediction in melanoma
2019
·
Hanna Saadani
, Bernies van der Hiel
, et al.
Show more works
View as search
Works count:
5
Citation count:
40
H-index:
3
I10-index:
1
Year
Topic
Type